Recce Pharmaceuticals Ltd

RECEF · OTC
Analyze with AI
$0.22+$0.00 (+0%)
At close:Dec 17, 2025, 9:00 PM UTC
$0.22+$0.00 (+0%)
After hours:Dec 17, 2025, 9:00 PM UTC
P/E TTM-6.74
P/B TTM-47.35
P/S TTM22.72
Dividend Yield0%
EPS-$0.06
Beta0.184
Valuation
PEG Ratio0.96
FCF Yield-12.00%
EV / EBITDA-6.34
Quality
ROIC-216.62%
Gross Margin-39.12%
Cash Conv. Ratio0.95
Growth
Revenue 3Y CAGR19.82%
FCF Growth-55.65%
Safety
Net Debt / EBITDA-0.01
Interest Coverage-18.16
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-55.11

Recce Pharmaceuticals Ltd (RECEF) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Recce Pharmaceuticals Ltd (RECEF) stock price today?

As of Dec 17, 2025, 9:00 PM UTC, Recce Pharmaceuticals Ltd (RECEF) stock is trading at $0.22. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date RECEF stock quotes for informed trading decisions.

What is Recce Pharmaceuticals Ltd's market capitalization?

Recce Pharmaceuticals Ltd (RECEF) has a market capitalization of approximately $76.5M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Recce Pharmaceuticals Ltd's size relative to other companies in the USD market. The market cap figure updates automatically as the RECEF stock price changes.

What is the 52-week range for Recce Pharmaceuticals Ltd stock?

Recce Pharmaceuticals Ltd (RECEF) stock has traded in a 52-week range of $0.22 — $0.60. The 52-week range shows the highest and lowest prices at which RECEF traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Recce Pharmaceuticals Ltd stock price to this range provides context for recent price action.

How much trading volume does Recce Pharmaceuticals Ltd stock have?

Recce Pharmaceuticals Ltd (RECEF) stock recently traded approximately 60 shares. Trading volume indicates market liquidity and investor interest in RECEF. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Recce Pharmaceuticals Ltd stock.

Does Recce Pharmaceuticals Ltd pay dividends to shareholders?

Yes, Recce Pharmaceuticals Ltd (RECEF) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Recce Pharmaceuticals Ltd stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Recce Pharmaceuticals Ltd's intraday price range?

Today, Recce Pharmaceuticals Ltd (RECEF) stock has traded in a range of $0.22 — $0.60. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring RECEF's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Recce Pharmaceuticals Ltd stock data?

AlphaPilot sources real-time RECEF stock quotes, fundamental financial data, and historical price charts for Recce Pharmaceuticals Ltd from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Recce Pharmaceuticals Ltd stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of RECEF stock performance.